IL-33-primed human mast cells drive IL-9 production by CD4+ effector T cells in an OX40L-dependent manner

Interleukin-33 (IL-33) is an alarmin released by epithelial cells in response to tissue damage. It activates resident immune sentinel cells, which then produce signals commonly associated with type 2 immune responses, particularly affecting infiltrating antigen-specific T cells. Given that mast cell...

Full description

Bibliographic Details
Published in:Frontiers in Immunology
Main Authors: Louise Battut, Edouard Leveque, Salvatore Valitutti, Nicolas Cenac, Gilles Dietrich, Eric Espinosa
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-10-01
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2024.1470546/full